# EDGAR Filing Document

**Accession Number:** 0001209466
**File Stem:** 0001209466-25-000623
**Filing Date:** 2025-12
**Character Count:** 15317
**Document Hash:** f1118feef2e80e42cba5733d8c87bb90
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001209466-25-000623.hdr.sgml**: 20251229

**ACCESSION NUMBER**: 0001209466-25-000623

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251031

**FILED AS OF DATE**: 20251229

**DATE AS OF CHANGE**: 20251229

**PERIOD START**: 20260430

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** INVESCO EXCHANGE-TRADED FUND TRUST
- **CENTRAL INDEX KEY:** 0001209466

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 0430

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-21265
- **FILM NUMBER:** 251604231

**BUSINESS ADDRESS:**
- **STREET 1:** 3500 LACEY ROAD
- **STREET 2:** SUITE 700
- **CITY:** DOWNERS GROVE
- **STATE:** IL
- **ZIP:** 60515
- **BUSINESS PHONE:** 800-983-0903

**MAIL ADDRESS:**
- **STREET 1:** 3500 LACEY ROAD
- **STREET 2:** SUITE 700
- **CITY:** DOWNERS GROVE
- **STATE:** IL
- **ZIP:** 60515

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** POWERSHARES EXCHANGE TRADED FUND TRUST
- **DATE OF NAME CHANGE:** 20021210

## Series and Classes Contracts Data

### Invesco Biotechnology & Genome ETF (Series ID: S000003026)

| Class ID   | Class Name                         | Ticker Symbol   |
|:---|:---|:---|
| C000008293 | Invesco Biotechnology & Genome ETF | PBE             |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Invesco Exchange-Traded Fund Trust

- **b. Investment Company Act file number:** 811-21265

- **c. CIK number of Registrant:** 0001209466

- **d. LEI of Registrant:** QPT4TMG79RF3UWNU0R52

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 3500 Lacey Road

  - **City:** Downers Grove

  - **State:** IL

  - **Foreign country:** US

  - **Zip / Postal Code:** 60515

  - **Telephone number:** 800-983-0903

**Item A.2. Information about the Series.**

- **a. Name of Series:** Invesco Biotechnology & Genome ETF

- **b. EDGAR series identifier (if any):** S000003026

- **c. LEI of Series:** 549300TC80GXFQLM7W73

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-04-30

- **b. Date as of which information is reported:** 2025-10-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $259254144.79

**Total Liabilities:** $25137477.46

**Net Assets:** $234116667.33

**Cash Not Reported:** $5728.00

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000008293 | 4.77%                | 2.30%                | 7.15%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $3435511.79              | $6654892.18                                |
| Month 2  | $11576372.59             | $-6510938.10                               |
| Month 3  | $167470.05               | $15565413.38                               |

### Schedule of Portfolio Investments

| Name                                  | Title                                                      | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Qiagen N.V.                           | Qiagen N.V.                                                | CUSIP: N72482206<br>LEI: 54930036WK3GMCN17Z57 | Long             | EC               | CORP              | NL        |    119237 | NS      | $5586259.79   | 2.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Collegium Pharmaceutical, Inc.        | Collegium Pharmaceutical, Inc.                             | CUSIP: 19459J104<br>LEI: 54930049FXZMTLW8D496 | Long             | EC               | CORP              | US        |    151110 | NS      | $5439960.00   | 2.32%             |  |  |  | No            |                  1 | On Loan: —       |
| Dynavax Technologies Corp.            | Dynavax Technologies Corp.                                 | CUSIP: 268158201<br>LEI: 549300T5URIXWDILX594 | Long             | EC               | CORP              | US        |    558037 | NS      | $5725459.62   | 2.45%             |  |  |  | No            |                  1 | On Loan: —       |
| Neurocrine Biosciences, Inc.          | Neurocrine Biosciences, Inc.                               | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |     42575 | NS      | $6097165.75   | 2.60%             |  |  |  | No            |                  1 | On Loan: No      |
| CorMedix Inc.                         | CorMedix Inc.                                              | CUSIP: 21900C308<br>LEI: 5299006YIA3L0MBW8358 | Long             | EC               | CORP              | US        |    416436 | NS      | $4634932.68   | 1.98%             |  |  |  | No            |                  1 | On Loan: —       |
| Acadia Pharmaceuticals Inc.           | Acadia Pharmaceuticals Inc.                                | CUSIP: 004225108<br>LEI: 529900O3044NO0PEA039 | Long             | EC               | CORP              | US        |    226512 | NS      | $5141822.40   | 2.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertex Pharmaceuticals Inc.           | Vertex Pharmaceuticals Inc.                                | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |     27597 | NS      | $11744455.29  | 5.02%             |  |  |  | No            |                  1 | On Loan: No      |
| BioMarin Pharmaceutical Inc.          | BioMarin Pharmaceutical Inc.                               | CUSIP: 09061G101<br>LEI: NSLL8ITTRR0J5HEMR848 | Long             | EC               | CORP              | US        |    101408 | NS      | $5432426.56   | 2.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals, Inc.       | Regeneron Pharmaceuticals, Inc.                            | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |     18176 | NS      | $11847116.80  | 5.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences, Inc.                 | Gilead Sciences, Inc.                                      | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |     93081 | NS      | $11150172.99  | 4.76%             |  |  |  | No            |                  1 | On Loan: No      |
| Royalty Pharma PLC                    | Royalty Pharma PLC, Class A                                | CUSIP: G7709Q104<br>LEI: 549300FGFN7VOK8BZR03 | Long             | EC               | CORP              | GB        |    296857 | NS      | $11144011.78  | 4.76%             |  |  |  | No            |                  1 | On Loan: No      |
| Incyte Corp.                          | Incyte Corp.                                               | CUSIP: 45337C102<br>LEI: 549300Z4WN6JVZ3T4680 | Long             | EC               | CORP              | US        |    127154 | NS      | $11886355.92  | 5.08%             |  |  |  | No            |                  1 | On Loan: No      |
| United Therapeutics Corp.             | United Therapeutics Corp.                                  | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |     18842 | NS      | $8392792.06   | 3.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Exelixis, Inc.                        | Exelixis, Inc.                                             | CUSIP: 30161Q104<br>LEI: 254900PJQB59O2O95R37 | Long             | EC               | CORP              | US        |    151956 | NS      | $5876138.52   | 2.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Biogen Inc.                           | Biogen Inc.                                                | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |     78120 | NS      | $12051572.40  | 5.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Halozyme Therapeutics, Inc.           | Halozyme Therapeutics, Inc.                                | CUSIP: 40637H109<br>LEI: 529900242I3SV9AGM753 | Long             | EC               | CORP              | US        |     79864 | NS      | $5206334.16   | 2.22%             |  |  |  | No            |                  1 | On Loan: No      |
| Veracyte, Inc.                        | Veracyte, Inc.                                             | CUSIP: 92337F107<br>LEI: 529900ESWZRHXOW27Z37 | Long             | EC               | CORP              | US        |    200411 | NS      | $7230828.88   | 3.09%             |  |  |  | No            |                  1 | On Loan: —       |
| Bio-Techne Corp.                      | Bio-Techne Corp.                                           | CUSIP: 09073M104<br>LEI: 54930073RLKQ51TILZ35 | Long             | EC               | CORP              | US        |    102586 | NS      | $6418806.02   | 2.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Sarepta Therapeutics, Inc.            | Sarepta Therapeutics, Inc.                                 | CUSIP: 803607100<br>LEI: 549300IKDPIED8J8IG21 | Long             | EC               | CORP              | US        |    319055 | NS      | $7660510.55   | 3.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Invesco Private Prime Fund            | Invesco Private Prime Fund                                 | CUSIP: N/A<br>LEI: N/A                        | Long             | STIV             | PF                | US        |  17960178 | NS      | $17960178.44  | 7.67%             |  |  |  | No            |                  2 | On Loan: No      |
| PTC Therapeutics, Inc.                | PTC Therapeutics, Inc.                                     | CUSIP: 69366J200<br>LEI: 549300UJLWOIWFDGB318 | Long             | EC               | CORP              | US        |    117792 | NS      | $8046371.52   | 3.44%             |  |  |  | No            |                  1 | On Loan: —       |
| Amgen Inc.                            | Amgen Inc.                                                 | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |     36883 | NS      | $11006993.69  | 4.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Exact Sciences Corp.                  | Exact Sciences Corp.                                       | CUSIP: 30063P105<br>LEI: 549300VM3X1FYD4N9Z14 | Long             | EC               | CORP              | US        |    126347 | NS      | $8173387.43   | 3.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Ionis Pharmaceuticals, Inc.           | Ionis Pharmaceuticals, Inc.                                | CUSIP: 462222100<br>LEI: 549300SI4ZGLG0BLUZ92 | Long             | EC               | CORP              | US        |    138155 | NS      | $10264916.50  | 4.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Catalyst Pharmaceuticals, Inc.        | Catalyst Pharmaceuticals, Inc.                             | CUSIP: 14888U101<br>LEI: 5299004O0R5XXLA5H544 | Long             | EC               | CORP              | US        |    292174 | NS      | $6214540.98   | 2.65%             |  |  |  | No            |                  1 | On Loan: No      |
| Illumina, Inc.                        | Illumina, Inc.                                             | CUSIP: 452327109<br>LEI: SQ95QG8SR5Q56LSNF682 | Long             | EC               | CORP              | US        |    108181 | NS      | $13364680.74  | 5.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Vericel Corp.                         | Vericel Corp.                                              | CUSIP: 92346J108<br>LEI: 54930076YM3PLTDR4B91 | Long             | EC               | CORP              | US        |    159832 | NS      | $5603709.92   | 2.39%             |  |  |  | No            |                  1 | On Loan: —       |
| MannKind Corp.                        | MannKind Corp.                                             | CUSIP: 56400P706<br>LEI: 213800GFBCNY1ZFST722 | Long             | EC               | CORP              | US        |   1431429 | NS      | $8001688.11   | 3.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Akebia Therapeutics, Inc.             | Akebia Therapeutics, Inc.                                  | CUSIP: 00972D105<br>LEI: 549300CBQEHMKEEGNX42 | Long             | EC               | CORP              | US        |   1885407 | NS      | $4166749.47   | 1.78%             |  |  |  | No            |                  1 | On Loan: —       |
| BioCryst Pharmaceuticals, Inc.        | BioCryst Pharmaceuticals, Inc.                             | CUSIP: 09058V103<br>LEI: 549300Z0INP1Z5NP6J59 | Long             | EC               | CORP              | US        |    679012 | NS      | $4970367.84   | 2.12%             |  |  |  | No            |                  1 | On Loan: —       |
| Invesco Government & Agency Portfolio | Invesco Government & Agency Portfolio, Institutional Class | CUSIP: 825252885<br>LEI: 5493007T1J7WZ5QI1A47 | Long             | STIV             | RF                | US        |    155557 | NS      | $155557.43    | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Invesco Private Government Fund       | Invesco Private Government Fund                            | CUSIP: N/A<br>LEI: N/A                        | Long             | STIV             | PF                | US        |   6900918 | NS      | $6900918.24   | 2.95%             |  |  |  | No            |                  2 | On Loan: No      |
| Madrigal Pharmaceuticals, Inc.        | Madrigal Pharmaceuticals, Inc.                             | CUSIP: 558868105<br>LEI: 549300CHIMT2EUSNJB60 | Long             | EC               | CORP              | US        |     13712 | NS      | $5743956.80   | 2.45%             |  |  |  | No            |                  1 | On Loan: —       |

### Signature

**Date Signed:** 2025-11-30

**Name of Applicant:** Invesco Exchange-Traded Fund Trust

**Signature:** Adrien Deberghes

**Name of Signer:** Adrien Deberghes

**Title:** Vice President